Unicycive Therapeutics (UNCY)

• Market cap: $145M
• 1 day: -3.15%
• 5 days: -2.03%
• 1 month: -2.17%
• 3 months: 9.72%
• 6 months: 57.81%
• Year to date: 16.72%
• 1 year: 30.19%
• 5 years: -88.43%
• 10 years: -88.43%
• Sector: Healthcare
• Industry: Biotechnology

About: Unicycive Therapeutics Inc is a biotechnology company dedicated to developing treatments for certain medical conditions. It is focusing on kidney diseases. The company's manufactures drug, Renazorb, is a novel phosphate-binding agent being developed for the treatment of hyperphosphatemia. Unicycive's other drug, UNI-494, is a new chemical entity with the issued composition of matter patent protection in late preclinical development for the treatment of acute kidney injury. Company's pipeline comprised of two product candidates: Oxylanthanum Carbonate and UNI-494.

Employees: 22